CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cadrenal Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.06−0.03 (-2.75%)
Close on Oct 19, 2026
- Market cap
- $3.09M
- P/E (TTM)
- –
- Dividend yield
- 1556.60%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$16.50
0.0% on the prior year
Consecutive increases
0 years
Not raised last year
Dividend yield
1556.60%
Latest annual dividend ÷ share price
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $16.50 | 0.0% | – | – |
| FY2024 | $16.50 | – | – | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.